These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35550848)

  • 1. WHO working group meeting to amend WHO Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines.
    Martin J; Barrett ADT; Lei D; Minor P
    Vaccine; 2022 Jun; 40(26):3490-3494. PubMed ID: 35550848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurovirulence, viscerotropism and immunogenicity of live attenuated yellow fever 17D vaccine virus in non-human primates.
    Tyagi P; Ganguly M; Manney S; Wadkar K; Ingle N; Gairola S; Dhere R; Koide F; Grimes S
    Vaccine; 2023 Jan; 41(3):836-843. PubMed ID: 36564277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models.
    Piras-Douce F; Raynal F; Raquin A; Girerd-Chambaz Y; Gautheron S; Sanchez MEN; Vangelisti M; Mantel N
    Vaccine; 2021 Mar; 39(13):1846-1856. PubMed ID: 33685778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13-14 May 2009.
    Ferguson M; Shin J; Knezevic I; Minor P; Barrett A;
    Vaccine; 2010 Dec; 28(52):8236-45. PubMed ID: 21055492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism.
    Wang HJ; Guo Y; He MJ; Liu ZY; Ye Q; Huang XY; Deng YQ; Li XF; Qin CF
    Microbiol Spectr; 2022 Oct; 10(5):e0224622. PubMed ID: 35980184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys.
    Marchevsky RS; Freire MS; Coutinho ES; Galler R
    Virology; 2003 Nov; 316(1):55-63. PubMed ID: 14599790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sanger-based sequencing technology for yellow fever vaccine genetic quality control.
    Pestana CP; Lawson-Ferreira R; Lessa-Aquino C; Leal MDLF; Freire MDS; Homma A; Medeiros MA
    J Virol Methods; 2018 Oct; 260():82-87. PubMed ID: 30009851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yellow fever vaccine. II. Antigenicity and neurovirulence of a vaccine seed free from avian leukosis virus.
    Tauraso NM; Spector SL; Kirschstein RL; Seligmann EB; Farber JF
    Appl Microbiol; 1969 Jun; 17(6):866-70. PubMed ID: 4307883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.
    Monath TP; Arroyo J; Levenbook I; Zhang ZX; Catalan J; Draper K; Guirakhoo F
    J Virol; 2002 Feb; 76(4):1932-43. PubMed ID: 11799188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yellow fever vaccine safety: a reality or a myth?
    Arya SC
    Vaccine; 2002 Nov; 20(31-32):3627-8. PubMed ID: 12399186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO working group meeting to develop WHO Recommendations to assure the quality, safety and efficacy of enterovirus 71 vaccines.
    Lei D; Griffiths E; Martin J
    Vaccine; 2020 Jul; 38(32):4917-4923. PubMed ID: 32418797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination.
    Levenbook IS; Pelleu LJ; Elisberg BL
    J Biol Stand; 1987 Oct; 15(4):305-13. PubMed ID: 3680299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yellow fever vaccine: comparison of the neurovirulence of new 17D-204 Stamaril™ seed lots and RK 168-73 strain.
    Moulin JC; Silvano J; Barban V; Riou P; Allain C
    Biologicals; 2013 Jul; 41(4):238-46. PubMed ID: 23763825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.
    Jentes ES; Poumerol G; Gershman MD; Hill DR; Lemarchand J; Lewis RF; Staples JE; Tomori O; Wilder-Smith A; Monath TP;
    Lancet Infect Dis; 2011 Aug; 11(8):622-32. PubMed ID: 21798462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
    Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
    Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and phenotypic analysis of a working seed lot of yellow fever virus 17DD vaccine strain produced from the secondary seed lot 102/84 with an additional passage in chicken embryos.
    Marchevsky RS; da Luz Leal M; Homma A; Coutinho ES; Camacho LA; Jabor AV; Galler R; Freire MS
    Biologicals; 2006 Sep; 34(3):191-7. PubMed ID: 16326110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.
    Monath TP; Myers GA; Beck RA; Knauber M; Scappaticci K; Pullano T; Archambault WT; Catalan J; Miller C; Zhang ZX; Shin S; Pugachev K; Draper K; Levenbook IS; Guirakhoo F
    Biologicals; 2005 Sep; 33(3):131-44. PubMed ID: 15975826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yellow fever vaccine: worthy friend or stealthy foe?
    Seligman SJ; Casanova JL
    Expert Rev Vaccines; 2016 Jun; 15(6):681-91. PubMed ID: 27087465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model.
    Julander JG; Testori M; Cheminay C; Volkmann A
    Front Immunol; 2018; 9():1756. PubMed ID: 30116244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.